277 results
Page 2 of 14
8-K
EX-2.1
euoiq 1wh325o
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
991mmq4a3ljfs81
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
azh9fxlm6se6
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
6iz3fp84
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
5ojuxsoro0uoisskog8m
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
z8zfhnt48
23 Mar 22
Business combination disclosure
5:29pm
8-K
3bd5omd70tgvuzqnda
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
vphqw bs31y8k2ia7
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
zmsjbpc53ecug
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
1movk stvzfis
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
9sw3ivvg2u2vln3
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
08wx5
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
0ss0jhsk
20 Oct 20
Results of Operations and Financial Condition
10:52am